"CpG 7909: PF 3512676, PF-3512676." DRUGS IN R&D 2006 LNKD- PUBMED:16922592, vol. 7, no. 5, 2006, pages 312-316, XP009078751 ISSN: 1174-5886 (B1)

ANGEL JONATHAN B ET AL: "CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection" JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES, BIOMED CENTRAL LTD., LONDON, GB LNKD- DOI:10.1186/1476-8518-6-4, vol. 6, no. 1, 12 August 2008 (2008-08-12) , page 4, XP021043811 ISSN: 1476-8518 (B1)

CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES: "Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices." 8 August 2003 (2003-08-08), MMWR. MORBIDITY AND MORTALITY WEEKLY REPORT 8 AUG 2003 LNKD- PUBMED:12908457, VOL. 52, NR. 31, PAGE(S) 739 - 740 , XP002597881 ISSN: 1545-861X the whole document (B1)

COOPER C L ET AL: "CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years." 15 April 2008 (2008-04-15), CLINICAL INFECTIOUS DISEASES : AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA 15 APR 2008 LNKD- PUBMED:18444872, VOL. 46, NR. 8, PAGE(S) 1310 - 1314 , XP002597878 ISSN: 1537-6591 the whole document (B1)

CORDONNIER CATHERINE ET AL: "Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation." CLINICAL INFECTIOUS DISEASES : AN OFFICIAL PUBLICATION OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA 15 MAY 2009 LNKD- PUBMED:19368505, vol. 48, no. 10, 14 April 2009 (2009-04-14), pages 1392-1401, XP002597880 ISSN: 1537-6591 (B1)

FEIKIN DANIEL R ET AL: "Specificity of the antibody response to the pneumococcal polysaccharide and conjugate vaccines in human immunodeficiency virus-infected adults." CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY JAN 2004 LNKD- PUBMED:14715560, vol. 11, no. 1, January 2004 (2004-01), pages 137-141, XP002597879 ISSN: 1071-412X (B1)

WO-A1-2008/079653 (B1)

KROON F P ET AL: "Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults" VACCINE, ELSEVIER LTD, GB LNKD- DOI:10.1016/S0264-410X(00)00232-2, vol. 19, no. 7-8, 22 November 2000 (2000-11-22), pages 886-894, XP004225408 ISSN: 0264-410X (B1)

OFFERSEN RASMUS ET AL: "TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults.", HUMAN VACCINES & IMMUNOTHERAPEUTICS AUG 2012, vol. 8, no. 8, August 2012 (2012-08), pages 1042-1047, ISSN: 2164-554X (B1)

SOGAARD OLE S ET AL: "Improving the immunogenicity of pneumococcal conjugate vaccine in HIV-infected adults with a toll-like receptor 9 agonist adjuvant: a randomized, controlled trial" CLINICAL INFECTIOUS DISEASES, THE UNIVERSITY OF CHICAGO PRESS, CHICAGO, IL, US, vol. 51, no. 1, 1 July 2010 (2010-07-01), pages 42-50, XP009137803 ISSN: 1058-4838 (B1)

SOGAARD OLE S ET AL: "Pneumococcal conjugate vaccination in persons with HIV: the effect of highly active antiretroviral therapy.", AIDS (LONDON, ENGLAND) 1 JUN 2010, vol. 24, no. 9, 1 June 2010 (2010-06-01), pages 1315-1322, ISSN: 1473-5571 (B1)

US-B1- 6 207 646 (B1)

US-B1- 6 214 806 (B1)

GUPTA KAVERI ET AL: "A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases" DRUGS IN R & D, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 9, no. 3, 1 January 2008 (2008-01-01) , pages 137-145, XP009137826 ISSN: 1174-5886 (B1)